{"id":830524,"date":"2025-03-27T08:18:32","date_gmt":"2025-03-27T12:18:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/wellgistics-health-annual-letter-to-shareholders-from-the-office-of-the-ceo-march-2025\/"},"modified":"2025-03-27T08:18:32","modified_gmt":"2025-03-27T12:18:32","slug":"wellgistics-health-annual-letter-to-shareholders-from-the-office-of-the-ceo-march-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/wellgistics-health-annual-letter-to-shareholders-from-the-office-of-the-ceo-march-2025\/","title":{"rendered":"Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025"},"content":{"rendered":"
\n

Dear Shareholders,<\/p>\n

\n TAMPA, FL, March 27, 2025 (GLOBE NEWSWIRE) — Wellgistics Health, Inc.<\/strong> (NASDAQ: WGRX) (\u201cWellgistics Health\u201d), This time last year, Wellgistics was a private company, weathering the pressures of a broken pharmaceutical supply chain plagued with waste, inefficiencies, and a lack of pricing transparency that has decimated independent pharmacies and other stakeholders in the healthcare ecosystem.<\/p>\n

Today, we are a public company listed on the Nasdaq exchange under our new parent company name, Wellgistics Health, Inc. (NASDAQ: WGRX), we have completed several acquisitions that broaden our service offerings, and we have a full year 2024 pro forma consolidated net sales (assuming our recent acquisitions had occurred as of January 1st, 2023) of $45.7 million, which is a 33% increase over the previous year, with a clear plan to scale our impact across healthcare.\u00b9<\/p>\n

\n What We Built in 2024<\/strong>\n <\/p>\n

We built an AI-enhanced end-to-end prescription processing platform\u2014Wellgistics Hub (formerly DelivMeds)\u2014that eliminates the guesswork for patients and providers.\u00a0<\/p>\n

When a provider writes a prescription\u2014either in-office or via telehealth\u2014our software checks the insurance, applies discounts when appropriate, and presents the patient with transparent out-of-pocket costs in real-time.<\/p>\n

If affordability is an issue, the patient can request a cheaper alternative through the Wellgistics Hub app\u2014triggering a seamless feedback loop between doctor and patient before the prescription is finalized. This simple loop addresses one of healthcare\u2019s most persistent failures: 30% of prescriptions are never filled due to cost.2<\/sup><\/p>\n

Once confirmed, the prescription can route to the patient\u2019s pharmacy of choice, or into our fulfillment network\u2014powered by over 5,000 independent pharmacies today, with many more expected as we continue to forge exciting relationships with group purchasing organizations (GPOs). Pharmacies can opt-in to our affiliate or active network, thereby improving efficiency, automation, and access to generic, brand and specialty drugs sourced directly through our NABP Accredited national distribution arm.<\/p>\n

In addition, we are excited to announce the launch of\u00a0EinsteinRx<\/em><\/strong>, a Wellgistics Health AI-driven internal intelligence decision support software that has been layered into our the core engine of Wellgistics Hub to guide smarter, faster prescription routing early in the prescription journey. It helps analyze patient demographics, pharmacy network and respective attributes, data, coverage, and therapeutic options in real-time to improve access and affordability with medications. As EinsteinRx continues to evolve, we expect that it will leverage machine learning to become more adaptive\u2014thereby reducing friction, eliminating barriers to adherence, and optimizing outcomes along the prescription journey.<\/p>\n

\n Why We\u2019re Different<\/strong>\n <\/p>\n

With our proprietary technology we are able to shift away from traditional sales channels and expensive marketing. Our providers and pharmacies become our ambassadors because we facilitate access and reduce administrative burden enabling pharmacists to focus on improving patient outcomes. We work with all stakeholders in the healthcare ecosystem to provide meaningful solutions to anticipate friction before it happens, engaging patients along the journey and not just at the point-of-sale.<\/p>\n

And we develop solutions based on what the market needs\u2014not guesswork. Every tool or feature we launch\u2014from our AI-enabled routing to our reimbursement automation engine\u2014is purpose-built based on industry trends, real world problems, and big data that we leverage from inside our network.<\/p>\n

\n Path to Profitability<\/strong>\u00a0<\/p>\n

Here\u2019s how we\u2019re building a high-growth, margin-rich business with strong market defensibility and one of the lowest customer acquisition costs in the healthcare ecosystem:<\/p>\n